UPC Analytics
ENDE
Overview · Filed: —

APL_8326/2025

METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

AppealsMain AppealCourt of AppealAppeal RoP220.2—
OverviewDecisionsCitationsDocumentsTimeline
Parties

Claimants

  • Accord Healthcare B.V.
  • Accord Healthcare S.L.U.
  • ACCORD HEALTHCARE LIMITED,
Reps: Wim Maas (Taylor Wessing)

Respondents

  • Novartis AG
Reps: Gregory Bacon (Bristows (Ireland) LLP)
Judges
  • Rian KaldenPresiding judge and judge-rapporteur
  • Ingeborg SimonssonLegally qualified judge
  • Patricia RombachLegally qualified judge
Patents
  • EP 2 501 384
CPC codes: A61P11/06, A61P37/06, A61P43/00, A61P17/00, A61P9/12, A61K31/506, A61P17/06, A61P19/02, A61P25/28, A61P35/00, A61K31/505, C07D239/69…

Sector: Organic Chemistry

Outcome
Procedural only
Filed: —
First decided: Apr 14, 2025
Language: —